# TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients

> **NCT00345592** · PHASE4 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 420 (actual)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DEVICE:** Dual (atrial and ventricular) implantable defibrillator
- **DEVICE:** Dual (atrial and ventricular) implantable defibrillator
- **DEVICE:** Dual (atrial and ventricular) implantable defibrillator

## Key facts

- **NCT ID:** NCT00345592
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2017-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00345592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00345592, "TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00345592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*